Filing Details

Accession Number:
0001179110-10-003363
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-22 12:00:00
Reporting Period:
2010-02-19
Filing Date:
2010-02-22
Accepted Time:
2010-02-22 18:22:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882095 Gilead Sciences Inc GILD Biological Products, (No Disgnostic Substances) (2836) 943047598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314870 Kristen Metza Gilead Sciences, Inc.
333 Lakeside Drive
Foster City CA 94404
Svp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-02-19 12,000 $28.26 18,203 No 4 M Direct
Common Stock Acquisiton 2010-02-19 8,000 $30.95 26,203 No 4 M Direct
Common Stock Acquisiton 2010-02-19 17,500 $32.79 43,703 No 4 M Direct
Common Stock Disposition 2010-02-19 37,500 $49.01 6,203 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-02-19 12,000 $0.00 12,000 $28.26
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-02-19 8,000 $0.00 8,000 $30.95
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-02-19 17,500 $0.00 17,500 $32.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,000 2016-05-09 No 4 M Direct
12,000 2016-07-26 No 4 M Direct
19,500 2017-01-22 No 4 M Direct
Footnotes
  1. The options have a five year vesting schedule. 20% of the options vested on May 9, 2007, the first anniversary date of the grant. The balance will vest 5% every three months thereafter until fully vested on May 9, 2011.
  2. The options have a five year vesting schedule. 20% of the options vested on July 26, 2007, the first anniversary date of the grant. The balance will vest 5% every three months thereafter until fully vested on July 26, 2011.
  3. The options have a five year vesting schedule. 20% of the options vested on January 22, 2008, the first anniversary date of the grant. The balance will vest 5% every three months thereafter until fully vested on January 22, 2012.
  4. Sale prices reported for the transactions reported here range from $48.9901 to $49.15. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request.